Credit rating agency, CARE has assigned ‘BBB-’ rating to Suven Life Sciences’ long term bank facilities worth Rs 105.56 crore. The rating agency has also assigned ‘A3’ rating to company’s Long-term Bank Facilities worth Rs 16.50 crore.
The company has received the said rating on back of its experienced promoter and management team, established track record under CRAMS with reputed clientele, strong Research & Development (R&D) competency, growing scale of operations with improving profitability margins and satisfactory gearing levels over the period.
Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.
